237 related articles for article (PubMed ID: 25211259)
1. Potential deleterious effects of promoting the use of ceftriaxone in the treatment of Neisseria gonorrhoeae.
Golden MR; Barbee LA; Kerani R; Dombrowski JC
Sex Transm Dis; 2014 Oct; 41(10):619-25. PubMed ID: 25211259
[TBL] [Abstract][Full Text] [Related]
2. Cephalosporin susceptibility among Neisseria gonorrhoeae isolates--United States, 2000-2010.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2011 Jul; 60(26):873-7. PubMed ID: 21734634
[TBL] [Abstract][Full Text] [Related]
3. Update to CDC's Sexually transmitted diseases treatment guidelines, 2010: oral cephalosporins no longer a recommended treatment for gonococcal infections.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2012 Aug; 61(31):590-4. PubMed ID: 22874837
[TBL] [Abstract][Full Text] [Related]
4. Will use of combination cephalosporin/azithromycin therapy forestall resistance to cephalosporins in Neisseria gonorrhoeae?
Rice LB
Sex Transm Infect; 2015 Jun; 91(4):238-40. PubMed ID: 25926405
[No Abstract] [Full Text] [Related]
5. Gonorrhea Treatment Failures With Oral and Injectable Expanded Spectrum Cephalosporin Monotherapy vs Dual Therapy at 4 Canadian Sexually Transmitted Infection Clinics, 2010-2013.
Singh AE; Gratrix J; Martin I; Friedman DS; Hoang L; Lester R; Metz G; Ogilvie G; Read R; Wong T
Sex Transm Dis; 2015 Jun; 42(6):331-6. PubMed ID: 25970311
[TBL] [Abstract][Full Text] [Related]
6. Single-dose cefixime versus single-dose ceftriaxone in the treatment of antimicrobial-resistant Neisseria gonorrhoeae infection.
Plourde PJ; Tyndall M; Agoki E; Ombette J; Slaney LA; D'Costa LJ; Ndinya-Achola JO; Plummer FA
J Infect Dis; 1992 Oct; 166(4):919-22. PubMed ID: 1527431
[TBL] [Abstract][Full Text] [Related]
7. Decreased susceptibility to cephalosporins among gonococci: data from the Gonococcal Resistance to Antimicrobials Surveillance Programme (GRASP) in England and Wales, 2007-2011.
Ison CA; Town K; Obi C; Chisholm S; Hughes G; Livermore DM; Lowndes CM;
Lancet Infect Dis; 2013 Sep; 13(9):762-8. PubMed ID: 23764300
[TBL] [Abstract][Full Text] [Related]
8. Variation in adherence to the treatment guidelines for Neisseria gonorrhoeae by clinical practice setting, California, 2009 to 2011.
Lechtenberg RJ; Samuel MC; Bernstein KT; Lahiff M; Olson N; Bauer HM
Sex Transm Dis; 2014 May; 41(5):338-44. PubMed ID: 24722391
[TBL] [Abstract][Full Text] [Related]
9. A randomized trial that compared oral cefixime and intramuscular ceftriaxone for the treatment of gonorrhea in pregnancy.
Ramus RM; Sheffield JS; Mayfield JA; Wendel GD
Am J Obstet Gynecol; 2001 Sep; 185(3):629-32. PubMed ID: 11568790
[TBL] [Abstract][Full Text] [Related]
10. Verified clinical failure with cefotaxime 1g for treatment of gonorrhoea in the Netherlands: a case report.
van Dam AP; van Ogtrop ML; Golparian D; Mehrtens J; de Vries HJ; Unemo M
Sex Transm Infect; 2014 Nov; 90(7):513-4. PubMed ID: 25114322
[TBL] [Abstract][Full Text] [Related]
11. Retreatment rates for uncomplicated gonorrhea infection: comparing ceftriaxone and azithromycin versus ceftriaxone and doxycycline.
Schumacher CM; Ghanem KG
Sex Transm Dis; 2013 Jul; 40(7):539-45. PubMed ID: 23965767
[TBL] [Abstract][Full Text] [Related]
12. A comparison of single-dose cefixime with ceftriaxone as treatment for uncomplicated gonorrhea. The Gonorrhea Treatment Study Group.
Handsfield HH; McCormack WM; Hook EW; Douglas JM; Covino JM; Verdon MS; Reichart CA; Ehret JM
N Engl J Med; 1991 Nov; 325(19):1337-41. PubMed ID: 1922235
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and Safety of Single-Dose Oral Delafloxacin Compared With Intramuscular Ceftriaxone for Uncomplicated Gonorrhea Treatment: An Open-Label, Noninferiority, Phase 3, Multicenter, Randomized Study.
Hook EW; Golden MR; Taylor SN; Henry E; Tseng C; Workowski KA; Swerdlow J; Nenninger A; Cammarata S
Sex Transm Dis; 2019 May; 46(5):279-286. PubMed ID: 30985632
[TBL] [Abstract][Full Text] [Related]
14. Treatment of gonococcal infection: when one drug is not enough.
Kransdorf LN; Kling JM; Mayer AP
J Womens Health (Larchmt); 2014 Jul; 23(7):627-8. PubMed ID: 24918549
[No Abstract] [Full Text] [Related]
15. Oral cefixime versus intramuscular ceftriaxone in patients with uncomplicated gonococcal infections.
Portilla I; Lutz B; Montalvo M; Mogabgab WJ
Sex Transm Dis; 1992; 19(2):94-8. PubMed ID: 1534422
[TBL] [Abstract][Full Text] [Related]
16. Preparing for an era of untreatable gonorrhea.
Barbee LA
Curr Opin Infect Dis; 2014 Jun; 27(3):282-7. PubMed ID: 24685549
[TBL] [Abstract][Full Text] [Related]
17. Time required for elimination of Neisseria gonorrhoeae from the urogenital tract in men with symptomatic urethritis: comparison of oral and intramuscular single-dose therapy.
Haizlip J; Isbey SF; Hamilton HA; Jerse AE; Leone PA; Davis RH; Cohen MS
Sex Transm Dis; 1995; 22(3):145-8. PubMed ID: 7652655
[TBL] [Abstract][Full Text] [Related]
18. Retrospective analysis of antimicrobial susceptibility trends (2000-2009) in Neisseria gonorrhoeae isolates from countries in Latin America and the Caribbean shows evolving resistance to ciprofloxacin, azithromycin and decreased susceptibility to ceftriaxone.
Starnino S; ; Galarza P; Carvallo ME; Benzaken AS; Ballesteros AM; Cruz OM; Hernandez AL; Carbajal JL; Borthagaray G; Payares D; Dillon JA
Sex Transm Dis; 2012 Oct; 39(10):813-21. PubMed ID: 23001269
[TBL] [Abstract][Full Text] [Related]
19. Implications of current recommendations for third-generation cephalosporin use in the WHO Western Pacific Region following the emergence of multiresistant gonococci.
Tapsall JW
Sex Transm Infect; 2009 Aug; 85(4):256-8. PubMed ID: 19261600
[TBL] [Abstract][Full Text] [Related]
20. Single-Dose Zoliflodacin (ETX0914) for Treatment of Urogenital Gonorrhea.
Taylor SN; Marrazzo J; Batteiger BE; Hook EW; Seña AC; Long J; Wierzbicki MR; Kwak H; Johnson SM; Lawrence K; Mueller J
N Engl J Med; 2018 Nov; 379(19):1835-1845. PubMed ID: 30403954
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
